share_log

Illumina Shares Are Trading Lower After Barclays Maintained an Underweight Rating on the Stock but Raised Its Price Target From $130 to $175. The Company on Thursday Presented at Its Inaugural Illumina Genomics Forum.

Illumina Shares Are Trading Lower After Barclays Maintained an Underweight Rating on the Stock but Raised Its Price Target From $130 to $175. The Company on Thursday Presented at Its Inaugural Illumina Genomics Forum.

在巴克莱维持对Illumina的减持评级,但将其目标价从130美元上调至175美元后,Illumina的股价下跌。该公司周四在其首届Illumina基因组学论坛上发表了讲话。
Benzinga ·  2022/09/30 10:06

Illumina shares are trading lower after Barclays maintained an Underweight rating on the stock but raised its price target from $130 to $175. The company on Thursday presented at its inaugural Illumina Genomics Forum.

在巴克莱维持对Illumina的减持评级,但将其目标价从130美元上调至175美元后,Illumina的股价下跌。该公司周四在其首届Illumina基因组学论坛上发表了讲话。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发